Advances, Promises, and Challenges in HIV Prevention

作者: Douglas Krakower , Kenneth H. Mayer

DOI: 10.1007/978-1-4614-8845-3_1

关键词:

摘要: As there are over two million new HIV infections each year, is a critical need for effective prevention strategies. Over the past 3 decades, studies have tested efficacy of numerous biomedical interventions that been developed to complement existing behavioral Until recently, few these were sufficiently efficacious merit broad implementation. However, several years, groundbreaking demonstrated primary and secondary interventions, which has revitalized field prevention. These promising include administration antiretroviral medications high-risk HIV-uninfected persons, known as preexposure prophylaxis, early treatment HIV-infected persons reduce their infectiousness, strategy referred “Treatment Prevention.” Voluntary medical male circumcision represents an additional intervention be undergoing scale-up in regions with generalized epidemics. faces barriers achieving optimal effectiveness, such substantial adherence challenges resulting conflicting results structural scaling-up therapy Treatment Prevention, cultural increasing uptake communities where practice not normative. If can overcome through scientific creativity, perseverance, political will, combination could help curb epidemic.

参考文章(111)
Felix M. Muchomba, Robin E. Gearing, Jane M. Simoni, Nabila El-Bassel, State of the science of adherence in pre-exposure prophylaxis and microbicide trials. Journal of Acquired Immune Deficiency Syndromes. ,vol. 61, pp. 490- 498 ,(2012) , 10.1097/QAI.0B013E31826F9962
Ian McGowan, Rectal microbicide development. Current Opinion in Hiv and Aids. ,vol. 7, pp. 526- 533 ,(2012) , 10.1097/COH.0B013E3283582BC2
A. David Paltiel, Rochelle P. Walensky, Home HIV Testing: Good News but Not a Game Changer Annals of Internal Medicine. ,vol. 157, pp. 744- 746 ,(2012) , 10.7326/0003-4819-157-10-201211200-00545
Julie B Dumond, Kristine B Patterson, Allison L Pecha, Rebecca E Werner, Emma Andrews, Bharat Damle, Randall Tressler, Jochen Worsley, Angela D M Kashuba, Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women. Journal of Acquired Immune Deficiency Syndromes. ,vol. 51, pp. 546- 553 ,(2009) , 10.1097/QAI.0B013E3181AE69C5
Lut Van Damme, Roshini Govinden, Florence M Mirembe, Fernand Guédou, Suniti Solomon, Marissa L Becker, BS Pradeep, AK Krishnan, Michel Alary, Bina Pande, Gita Ramjee, Jennifer Deese, Tania Crucitti, Doug Taylor, None, Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. The New England Journal of Medicine. ,vol. 359, pp. 463- 472 ,(2008) , 10.1056/NEJMOA0707957
Elisabeth Maria Van der Elst, Judie Mbogua, Don Operario, Gaudensia Mutua, Caroline Kuo, Peter Mugo, Jennifer Kanungi, Sagri Singh, Jessica Haberer, Frances Priddy, Eduard Joachim Sanders, High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya Aids and Behavior. ,vol. 17, pp. 2162- 2172 ,(2013) , 10.1007/S10461-012-0317-8
Peter A. Anton, Ross D. Cranston, Angela Kashuba, Craig W. Hendrix, Namandjé N. Bumpus, Nicola Richardson-Harman, Julie Elliott, Laura Janocko, Elena Khanukhova, Robert Dennis, William G. Cumberland, Chuan Ju, Alex Carballo-Diéguez, Christine Mauck, Ian McGowan, RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate AIDS Research and Human Retroviruses. ,vol. 28, pp. 1412- 1421 ,(2012) , 10.1089/AID.2012.0262
Morgane Rolland, Peter Gilbert, Evaluating Immune Correlates in HIV Type 1 Vaccine Efficacy Trials: What RV144 May Provide AIDS Research and Human Retroviruses. ,vol. 28, pp. 400- 404 ,(2012) , 10.1089/AID.2011.0240
Jaclyn M. White, Matthew J. Mimiaga, Douglas S. Krakower, Kenneth H. Mayer, Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. Aids Patient Care and Stds. ,vol. 26, pp. 395- 405 ,(2012) , 10.1089/APC.2012.0030
J. Gerardo García-Lerma, Walid Heneine, Animal models of antiretroviral prophylaxis for HIV prevention. Current Opinion in Hiv and Aids. ,vol. 7, pp. 505- 513 ,(2012) , 10.1097/COH.0B013E328358E484